The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of DFP-11207, a novel oral 5-FU with enhanced PK and improved tolerability, in patients with solid tumors.
 
Jaffer A. Ajani
Honoraria - Aduro Biotech; Bristol-Myers Squibb; Lilly; Merck
Consulting or Advisory Role - American Cancer Society; BeiGene; Bristol-Myers Squibb; Insys Therapeutics; Merck; Vaccinogen
Research Funding - Amgen; Bristol-Myers Squibb; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; Roche/Genentech; Taiho Pharmaceutical; Takeda
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
 
Milind M. Javle
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen
 
Cathy Eng
Honoraria - Bayer; Celgene; Roche; Sirtex Medical
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Advaxis; Forty Seven; Genentech/Roche; Keryx
Travel, Accommodations, Expenses - Bayer; Genentech/Roche; Sirtex Medical
 
David R. Fogelman
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Barry Douglas Anderson
No Relationships to Disclose
 
Chun Zhang
Employment - Delta-Fly Pharma
 
Kenzo Iizuka
Employment - Delta-Fly Pharma
Leadership - Delta-Fly Pharma